These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34980315)

  • 21. Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility.
    Kumar A; Brar R; Wang P; Dee L; Skorupa G; Khadour F; Schulz R; Parrillo JE
    Am J Physiol; 1999 Jan; 276(1):R265-76. PubMed ID: 9887205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The soluble guanylate cyclase activator BAY 58-2667 protects against morbidity and mortality in endotoxic shock by recoupling organ systems.
    Vandendriessche B; Rogge E; Goossens V; Vandenabeele P; Stasch JP; Brouckaert P; Cauwels A
    PLoS One; 2013; 8(8):e72155. PubMed ID: 24015214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late, but not early, inhibition of soluble guanylate cyclase decreases mortality in a rat sepsis model.
    Fernandes D; Sordi R; Pacheco LK; Nardi GM; Heckert BT; Villela CG; Lobo AR; Barja-Fidalgo C; Assreuy J
    J Pharmacol Exp Ther; 2009 Mar; 328(3):991-9. PubMed ID: 19073910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blockade of the action of nitric oxide in human septic shock increases systemic vascular resistance and has detrimental effects on pulmonary function after a short infusion of methylene blue.
    Weingartner R; Oliveira E; Oliveira ES; Sant'Anna UL; Oliveira RP; Azambuja LA; Friedman G
    Braz J Med Biol Res; 1999 Dec; 32(12):1505-13. PubMed ID: 10585632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Administration of methylene blue in septic shock: pros and cons.
    Arias-Ortiz J; Vincent JL
    Crit Care; 2024 Feb; 28(1):46. PubMed ID: 38365828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclic GMP and guanylate cyclase mediate lipopolysaccharide-induced Kupffer cell tumor necrosis factor-alpha synthesis.
    Harbrecht BG; Wang SC; Simmons RL; Billiar TR
    J Leukoc Biol; 1995 Feb; 57(2):297-302. PubMed ID: 7852845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Administration of methylene blue in human septic shock: renaissance of an old drug?
    Evgenov OV; Bjertnaes LJ
    Crit Care Med; 2003 May; 31(5):1601-2; author reply 1602. PubMed ID: 12771654
    [No Abstract]   [Full Text] [Related]  

  • 28. Autoregulation of nitric oxide-soluble guanylate cyclase-cyclic GMP signalling in mouse thoracic aorta.
    Hussain MB; Hobbs AJ; MacAllister RJ
    Br J Pharmacol; 1999 Nov; 128(5):1082-8. PubMed ID: 10556946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does methylene blue administration to septic shock patients affect vascular permeability and blood volume?
    Donati A; Conti G; Loggi S; Münch C; Coltrinari R; Pelaia P; Pietropaoli P; Preiser JC
    Crit Care Med; 2002 Oct; 30(10):2271-7. PubMed ID: 12394955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylene blue increases myocardial function in septic shock.
    Daemen-Gubbels CR; Groeneveld PH; Groeneveld AB; van Kamp GJ; Bronsveld W; Thijs LG
    Crit Care Med; 1995 Aug; 23(8):1363-70. PubMed ID: 7634806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of methylene blue for refractory septic shock during continuous venovenous hemodiafiltration.
    Mount JC; Rowe AS
    Pharmacotherapy; 2010 Mar; 30(3):323. PubMed ID: 20180614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relaxation of retinal pericyte contractile tone through the nitric oxide-cyclic guanosine monophosphate pathway.
    Haefliger IO; Zschauer A; Anderson DR
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):991-7. PubMed ID: 7907321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhaled nitric oxide decreases pulmonary soluble guanylate cyclase protein levels in 1-month-old lambs.
    Thelitz S; Bekker JM; Ovadia B; Stuart RB; Johengen MJ; Black SM; Fineman JR
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1285-92. PubMed ID: 15115984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nitric oxide pathways in human bladder carcinoma. The distribution of nitric oxide synthases, soluble guanylyl cyclase, cyclic guanosine monophosphate, and nitrotyrosine.
    Ehsan A; Sommer F; Schmidt A; Klotz T; Koslowski J; Niggemann S; Jacobs G; Engelmann U; Addicks K; Bloch W
    Cancer; 2002 Dec; 95(11):2293-301. PubMed ID: 12436434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of methylene blue on hemodynamic parameters and cytokine levels in refractory septic shock.
    Park BK; Shim TS; Lim CM; Lee SD; Kim WS; Kim DS; Kim WD; Koh Y
    Korean J Intern Med; 2005 Jun; 20(2):123-8. PubMed ID: 16134766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasopressor-Sparing Action of Methylene Blue in Severe Sepsis and Shock: A Narrative Review.
    Puntillo F; Giglio M; Pasqualucci A; Brienza N; Paladini A; Varrassi G
    Adv Ther; 2020 Sep; 37(9):3692-3706. PubMed ID: 32705530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylene blue increases systemic vascular resistance in human septic shock. Preliminary observations.
    Schneider F; Lutun P; Hasselmann M; Stoclet JC; Tempé JD
    Intensive Care Med; 1992; 18(5):309-11. PubMed ID: 1527264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitric oxide inhibition in the treatment of septic shock.
    Hata JS; Dellinger RP
    Crit Care Med; 1995 Oct; 23(10):1621-4. PubMed ID: 7587224
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibition of nitric oxide synthesis by methylene blue.
    Mayer B; Brunner F; Schmidt K
    Biochem Pharmacol; 1993 Jan; 45(2):367-74. PubMed ID: 7679577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of methylene blue in sepsis: a systematic review.
    Kwok ES; Howes D
    J Intensive Care Med; 2006; 21(6):359-63. PubMed ID: 17095500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.